SCHEMBL458238

SCHEMBL458238

Cc1ccc(F)c(C=C[N+](=O)[O-])c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FBP1 P09467 10/20 0.53
VCP P55072 2/20 0.49
MEN1 O00255 1/20 0.48
PSMD14 O00487 1/20 0.48
KMT2A Q03164 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
ALDH1A1 P00352 3/20 0.43
MAPT P10636 3/20 0.43
LMNA P02545 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
RXRA P19793 1/20 0.40
MITF O75030 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HPGD P15428 1/20 0.40
NTSR1 P30989 1/20 0.40
PRMT1 Q99873 1/20 0.40
AKR1B1 P15121 1/20 0.39
HSP90AA1 P07900 1/20 0.39
HTT P42858 1/20 0.39
CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL458434 1.00 FBP1 (0.53) FBP1VCPMEN1PSMD14KMT2A
SCHEMBL18590413 0.86 FBP1 (0.58) FBP1VCPMEN1PSMD14KMT2A
SCHEMBL612346 0.82 FBP1 (0.56) FBP1VCPMEN1PSMD14KMT2A
SCHEMBL612345 0.82 FBP1 (0.56) FBP1VCPMEN1PSMD14KMT2A
SCHEMBL18524374 0.79 VCP (0.57) FBP1VCPMEN1PSMD14KMT2A
SCHEMBL29273221 0.79 FBP1 (0.53) FBP1VCPMEN1PSMD14KMT2A
SCHEMBL18524372 0.79 VCP (0.57) FBP1VCPMEN1PSMD14KMT2A
SCHEMBL459698 0.79 FBP1 (0.57) FBP1VCPMEN1PSMD14KMT2A
SCHEMBL458371 0.79 FBP1 (0.57) FBP1VCPMEN1PSMD14KMT2A
SCHEMBL11077530 0.79 FBP1 (0.56) FBP1VCPMEN1PSMD14KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013026587-A1 1,4 DISUBSTITUTED PYRROLIDINE - 3 - YL -AMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS PROSIDION LIMITED (GB) 2013-02-28 WO disclosed
WO-2012066077-A1 1,4 DI SUBSTITUTED PYRROLIDINE - 3 - YL -AMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS PROSIDION LIMITED (GB) 2012-05-24 WO disclosed
WO-2011147951-A1 CYCLOAMINO DERIVATIVES AS GPR119 ANTAGONISTS PROSIDION LIMITED (GB) 2011-12-01 WO disclosed